BioSpace News Archive

Researchers Identify Molecule Produced During Exercise that Reduces Obesity

Researchers from the Baylor College of Medicine, Stanford School of Medicine and others discovered a molecule produced during exercise in mice that suppresses feeding and obesity.

June 17, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

FDA Grants Orphan Drug Designations to VBI, Hepion Cancer Drugs

VBI Vaccines and Hepion Pharmaceuticals have received Orphan Drug Designations from the U.S. Food and Drug Administration for their experimental cancer drugs.

June 17, 2022
·
3 min read
·
Mark Terry
Business

Report: Merck Looks into Possible Buyout of Seagen

Pharmaceutical giant Merck is exploring a possible purchase of biotech company Seagen, according to The Wall Street Journal.

June 17, 2022
·
2 min read
·
Geoff Herman
Policy

Acadia’s Alzheimer’s Drug Voted Down by FDA Advisory Committee

An FDA advisory committee voted against Acadia Pharmaceutical’s supplemental New Drug Application of Nuplazid tablets for the treatment of Alzheimer’s-related psychosis.

June 17, 2022
·
3 min read
·
Mark Terry
Drug Development

Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson’s Disease due to Slow Recruitment Rate

Addex Therapeutics Ltd announced that it has terminated the Phase 2b/3 study evaluating dipraglurant as a potential treatment for dyskinesia associated with Parkinson’s disease due to the slow recruitment of patients.

June 17, 2022
·
4 min read
Bio NC

Cresemba® sales in Asia Pacific region trigger sales milestone payment to Basilea from Pfizer

Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company, announced that the sales of the antifungal Cresemba® by its license partner Pfizer Inc. in the Asia Pacific region, exceeded the threshold triggering the first sales milestone payment for this region of USD 1.25 million.

June 17, 2022
·
4 min read
Policy

Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

RELIEF THERAPEUTICS Holding SA, announced that it has filed Amendment No. 3 to its Registration Statement on Form 20‑F with the U.S. Securities and Exchange Commission.

June 17, 2022
·
4 min read
Business

Syngenta Group Announces Leadership Transition

Syngenta Group announced succession plans for its leadership team. Jeff Rowe, currently President, Global Seeds, will take over the leadership of Syngenta Crop Protection, effective July 1, 2022.

June 17, 2022
·
5 min read
Disinfectants Market to be Worth US$ 14.9 Bn by the End 2030, Rise in Awareness about Cleanliness and Hygiene among Population to Drive Market

Wilmington, Delaware, United States: According to the report, the global disinfectants market was valued over US$ 6.9 Bn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

June 17, 2022
·
5 min read
Biomedical Refrigerators and Freezers Market: Trends, Regional Outlook and Competitive Analysis [2021-2031]

Biomedical refrigerators and freezers are utilized as a part of medicine and biotechnology.

June 17, 2022
·
8 min read